Princeton Capital Management Inc’s Novo Nordisk NVO Stock Holding History

Princeton Capital Management Inc’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$2.64M	Buy	109,762 +8,972	+9%	+$203K	1.34%	27
2017 Q2	$2.16M	Sell	100,790 -9,356	-8%	-$189K	1.36%	28
2017 Q1	$1.89M	Sell	110,146 -1,818	-2%	-$31.7K	1.19%	28
2016 Q4	$2.01M	Sell	111,964 -3,578	-3%	-$64.9K	1.34%	27
2016 Q3	$2.4M	Buy	115,542 +1,654	+1%	+$41K	1.57%	26
2016 Q2	$3.06M	Buy	113,888 +23,466	+26%	+$644K	2.11%	20
2016 Q1	$2.45M	Buy	90,422 +43,214	+92%	+$1.16M	1.7%	24
2015 Q4	$1.37M	Buy	+47,208	New	+$1.31M	0.97%	33

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

Princeton Capital Management Inc's NVO Position: Q3 2017 in Review

Princeton Capital Management Inc increased its Novo Nordisk (NVO) stake by 8.9% in Q3 2017, buying an estimated $203K and bringing the position to 109,762 shares worth $2.64M. The position accounts for 1.34% of the portfolio, ranked #27.

Princeton Capital Management Inc first reported a position in NVO in Q4 2015 and has held it in 8 quarters since. The position peaked at $3.06M in Q2 2016. 491 funds tracked by Wall St. Rank hold NVO as of Q3 2017.

Princeton Capital Management Inc held 109,762 shares of Novo Nordisk worth $2.64M as of Q3 2017.
Princeton Capital Management Inc bought 8,972 Novo Nordisk shares in Q3 2017, an estimated $203K.
Novo Nordisk made up 1.34% of Princeton Capital Management Inc's portfolio in Q3 2017, its #27 holding.
Princeton Capital Management Inc first reported a position in Novo Nordisk in Q4 2015 and has held it in 8 quarters since.
Princeton Capital Management Inc's Novo Nordisk position peaked at $3.06M in Q2 2016.
491 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2017.

Based on Princeton Capital Management Inc's 13F filing for Q3 2017, filed 3 Nov 2017.